In a landmark advancement set to revolutionize surgical procedures, Wayne State University, in partnership with RediMinds Inc., has secured a patent for an innovative technology designed to detect and visualize arterial bleeding during minimally invasive surgeries. The newly granted United States Patent No. 12,635,098 B2, issued on May 26, 2026, represents a pivotal leap in surgical safety, addressing one of the most challenging complications faced by surgeons—unexpected intraoperative bleeding. This development holds the promise of dramatically improving patient outcomes in robotic and laparoscopic surgeries, where precise control over bleeding is critical.

Minimally invasive surgical procedures, including robotic and laparoscopic surgeries, have transformed the medical landscape by reducing recovery times and minimizing trauma. However, they are not without significant risks. Among these, arterial bleeding is a particularly severe complication. When bleeding occurs unexpectedly inside the surgical field, it can obscure the surgeon’s view, creating a dangerous scenario termed a “red out.” This occlusion of the visual field complicates the surgeon’s ability to manage the procedure effectively, potentially leading to adverse patient outcomes including increased mortality.

Led by Dr. Abhilash K. Pandya, a professor of electrical and computer engineering at Wayne State’s James and Patricia Anderson College of Engineering, the research incorporates cutting-edge computer vision and machine learning technologies. These sophisticated techniques analyze real-time data from the surgical camera, enabling the system to detect the onset of arterial bleeding instantly. The patented system goes beyond simple detection by providing precise localization and assessment of the bleeding source, which is then visually communicated to the surgeon through augmented reality overlays.

The core innovation lies in the seamless integration of artificial intelligence (AI) with existing surgical visualization tools. Surgical cameras already provide live video feeds during operations, but this technology enhances those feeds with AI-driven analysis that identifies bleeding with remarkable accuracy. By superimposing detailed visual cues onto the real-time surgical view, it guides the surgeon to the exact location of arterial injury, thus enabling swift and targeted intervention to control the bleeding.

This bleeding management system is designed as an add-on module compatible with the more than 2,000 robotic and 7,000 laparoscopic surgical systems currently deployed across hospitals in the United States. Its compatibility ensures that existing surgical infrastructure can be upgraded without requiring entirely new equipment, facilitating rapid adoption and widespread impact across healthcare institutions. The potential integration signals a significant stride toward the era of AI-assisted surgery, where technology acts as a vigilant partner alongside the surgeon.

Dr. Pandya emphasized the strategic importance of this development, describing the patented technology as a precursor to more sophisticated AI support systems in the operating room. Such systems are envisioned to monitor a variety of critical parameters beyond bleeding, including patient vitals and surgeon fatigue, providing timely warnings and augmenting human decision-making during complex surgical interventions. This holistic approach could transform surgical safety by proactively preventing complications and enhancing the surgeon’s situational awareness.

The implications of this advancement are profound. The ability to monitor and manage intraoperative bleeding with high precision is expected to minimize the need for blood transfusions, reduce infection rates, and decrease the length of hospital stays, all contributing to improved patient welfare and lower healthcare costs. Moreover, the technology holds promise in advancing intelligent safety tools that will serve as safeguards in the challenging environment of modern surgery, where every second and detail matter.

Dean Ali Abolmaali of the James and Patricia Anderson College of Engineering highlighted the interdisciplinary nature of the project, which synthesizes expertise in artificial intelligence, computer vision, and medical science. This synergy exemplifies how engineering innovations are poised to tackle complex healthcare challenges by translating laboratory discoveries into practical technologies with tangible benefits. The research portfolio showcased by Dr. Pandya and his collaborators illustrates the kind of transformative work that positions Wayne State University at the forefront of health-related engineering advancements.

From a commercialization perspective, Wayne State University’s commitment to transitioning early-stage innovations into market-ready solutions was underscored by Taunya Phillips, assistant vice president for technology commercialization at Wayne State. Securing this patent is a critical milestone in protecting intellectual property and ensuring that the invention not only advances science but also delivers societal and economic benefits. The collaboration between academic research and industry partners stands as a model for accelerating the impact of scientific breakthroughs on real-world medical practice.

As surgical procedures continue to evolve with the integration of robotics and AI, technologies like Dr. Pandya’s bleeding detection system portend a future where surgical errors and complications due to visual impairment from bleeding could become significantly less common. By automating the detection and localization process, this system frees surgeons to focus on critical decision-making and precision control, ultimately enhancing the safety and effectiveness of surgical interventions.

In closing, this patented technology heralds a new chapter in surgical innovation, leveraging AI to provide augmented reality-enhanced visualization that directly addresses the critical challenge of intraoperative bleeding. With the potential to save lives and improve surgical outcomes nationwide, this invention exemplifies how academic ingenuity can lead to global healthcare improvements. As adoption grows, the promise of AI as a vigilant and trustworthy assistant in the operating room moves closer to reality.

Subject of Research: Artificial Intelligence and Computer Vision Applications in Surgical Safety

Article Title: Wayne State University Secures Patent for AI-Driven Arterial Bleeding Detection System in Surgery

News Publication Date: May 26, 2026

Web References: research.wayne.edu

Image Credits: Wayne State University

Keywords

Applied sciences and engineering, Engineering, Human health, Biomedical engineering, Surgery

When a person loses a limb, a prosthesis often can help restore a significant degree of mobility. But

University of California, Irvine researchers have invented a wearable, wireless, battery-free, bioelectronic sensor to monitor users’ health by

Researchers in Japan have succeeded in measuring the temperature inside living cells with high precision using a new class of biocompatible quantum nanosensor – something that has been difficult to do until now even. If improved, the nanosensor could be used to characterize a wide range of biological phenomena and so help in disease diagnosis, they say.

Recent years have seen the advent of a new generation of nanoscale quantum sensors that can detect the tiny magnetic fields of biological systems. Some of these sensors rely on photons and others on electrons or spin defects – typically diamond specially engineered with nitrogen–vacancy (NV) defects. This material is made by removing two carbon atoms from the diamond lattice and replacing one with a nitrogen atom. The other “hole” is left empty, thereby creating a vacancy or defect. The spin state of the defect is influenced by the local magnetic field that can be “read out” from the way it fluoresces.

While a powerful tool, and biocompatible, this type of quantum sensor does suffer from certain limits. For one, it can be structurally inhomogeneous, which affects how it detects temperature and other physical or chemical parameters inside biological cells.

A more homogenous structure

Even though the new molecular quantum nanosensor (MoQN) works in the same way as these conventional devices, it does not suffer from this problem, explain Nobuhiro Yanai of the University of Tokyo and Hitoshi Ishiwata of the National Institutes for Quantum Science and Technology (QST), who led this research effort. This is because it has a more homogenous structure and does not contain any defects. Instead, it is made by embedding molecular spin qubits, in this case fabricated from pentacene, in nanocrystals of para-terphenyl. This design makes the structure uniform on a molecular scale and preserves the quantum coherence of the spin qubits. It is then coated with Pluronic F127, which is a biocompatible surfactant.

By detecting the spin direction of the “excited triplet state” of the pentacene qubits using a technique known as optically detected magnetic resonance (OMDR), the researchers can precisely determine the temperature of the qubits’ surroundings from the OMDR peak position. When they tested their method inside the cytoplasm of cancer cells in vivo, they found that the intracellular temperature was consistently higher than the surrounding medium.

Yanai says he embarked on this study after reading about the work of Sam Bayliss’ group at the UK’s University of Glasgow, and Ashok Ajoy’s group at the University of California, Berkeley in the US on OMDR in pentacene-doped para-terphenyl crystals. He says he immediately got the idea that nanocrystals of this material could be used for quantum sensing inside cells. This was because his group had already developed such nanocrystals for a different purpose in previous research.

Ensuring biocompatibility

“I then spoke with Hitoshi Ishiwata, who is an expert in quantum sensing using NV centres,” he recalls. “While many molecular qubits have been developed to date, there had been no examples demonstrating their sensing ability within living cells.”

The project required materials science expertise, he tells Physics World, and in particular, finding out how to reduce the material to the nanoscale and ensuring it was biocompatible.

“We already knew that nanodiamonds are good quantum sensors for temperature measurements, but I had noticed a practical limitation: their ODMR spectra often vary significantly from particle to particle,” he says. “This spectral dispersion can introduce errors, especially when trying to perform precise measurements at the single-particle level.”

Replacing hydrogen with deuterium

The researchers thought they had overcome this problem during the first run of their experiments because they found that different particles showed identical OMDR spectra. However, their joy quickly waned when they observed that the spectra were still broadened by hyperfine interactions between the pentacene-doped para-terphenyl molecules’ electron spins and hydrogen nuclear spins.

To improve the spectral resolution, Ishiwata says he suggested chemically modifying the molecule by replacing the hydrogen in it with deuterium. And the technique worked: “the hyperfine broadening was strongly suppressed, allowing us to determine the OMDR spectra much more precisely.”

These findings, which are detailed in Science Advances, show that MoQNs are a chemically versatile platform for quantum sensing in living cells and that they can operate directly inside them while maintaining the precision needed for absolute thermometry, he says. Their appeal also lies in in the fact that their structures can be easily modified.

It will not all be plain sailing, however, adds Yanai. MoQNs cannot yet target specific organelles within cells, so endowing them with this targeting capability is an important future challenge. “What is more, their size has been limited to around 200 nm so far, so creating smaller MoQN particles will be crucial,” he says.

The post Molecular spin sensor takes the temperature of cancer cells appeared first on Physics World.